Unveiling a Revolutionary Approach to Drug Discovery through Proteomics and Genetics
TL;DR
The Pharma Proteomics Project, a collaboration between 13 pharmaceutical companies and the UK Biobank, has discovered numerous new leads for drug targets and diagnostic biomarkers by analyzing genetic data and blood proteins from 54,000 individuals. This research has the potential to uncover the causes of common conditions and has revealed thousands of previously unknown associations between common genetic variants and circulating proteins in the blood.
Topics:businessscience-and-technology#biomarkers#blood-proteins#drug-targets#genetic-variants#pharma-proteomics-project#science-and-technology
- A treasure trove of new leads on drug targets and biomarkers has been uncovered in a huge proteomics study Endpoints News
- AstraZeneca reveals new research to improve drug discovery PharmaTimes
- AstraZeneca set to transform drug discovery with gamechanging proteogenomics model Business Weekly
- Large-scale plasma proteomics comparisons through genetics and disease associations Nature.com
- Largest dataset of thousands of proteins a landmark step for research into human health Medical Xpress
- View Full Coverage on Google News
Want the full story? Read the original reporting
Read on Endpoints News